Retrospective Study of Aging and Sex-Specific Risk Factors of COVID-19 with Hypertension in China

Table 4

Risk factors associated with COVID-19 patients with hypertension.

	Univariable OR; (95% CI)	value	Multivariable OR; (95% CI)	value
Demographics
Age	1.05 (1.03–1.07)	0.121	1.04 (1.00–1.19)	<0.001
Comorbidities
Diabetes	3.734 (1.965–7.096)	<0.001	3.112 (1.339–6.924)	0.005
Coronary heart disease	8.159 (2.828–23.537)	<0.001	8.815 (2.574–30.189)	0.001
Cerebral vascular disease	4.11 (1.082–15.614)	0.038
Laboratory findings
Globulin, g/L
< 20	3.503 (0.625–19.64)	0.154
20–30	1 (ref)	—
> 30	—	—
Triglyceride, mmol/L
0.24–1.86	1 (ref)	—
> 1.86	1.948 (0.664–2.355)	0.771
High density lipoprotein, mmol/L
< 1.03	107.209 (1.48–127.81)	0.033	123.67 (1.39–137.94)	<0.001
1.03–1.55	1 (ref)	—
> 1.55	0.581 (0.04–8.501)	0.692
Neutrophil count, ×10^9 per L	0.994 (0.63–1.081)	0.09
Lymphocyte count, ×10^9 per L	0.982 (0.966–1.998)	0.032	0.797 (0.628–1.899)	0.033
<0.8	1.146 (0.023–1.937)	0.043	2.532 (0.987–2.900)	0.028
0.8–4	1 (ref)	—
>4	—	—
Lymphocyte percentage, %
< 20	0.928 (0.863–0.998)	0.043
20–40	1 (ref)	—
>40	—	—
Monocyte count, ×10^9 per L	1.501 (1.035–2.175)	0.032
Mean hemoglobin, pg
< 27	0.935 (0.742–1.178)	0.57
27–31	1 (ref)	—
> 31	0.645 (0.392–1.061)	0.084
Basophil percentage, ×10^9 per L	0.327 (0.094–1.136)	0.079
Haemoglobin, g/L
< 115	1.064 (0.99–1.144)	0.093
115–150	1 (ref)	—
> 150	0.924 (0.837–1.02)	0.119
Red blood cell distribution width SD, fL	0.937 (0.889–0.998)	0.015	0.851 (0.793–0.913)	<0.001
Thrombin time, s	1.121 (0.993–1.265)	0.064	1.507 (1.280–1.774)	<0.001
Glucose	7.03 (1.87–22.30)	0.0079	4.85 (0.76–39.81)	0.049
D-dimer, mg/L	1.768 (0.876–6.77)	0.089	2.111 (0.56–8.796)	0.05